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When pathogens come into contact with
their respective host, they immediately
encounter the broad diversity of the
current cellular proteome which usually
consists of several thousand different pro-
teins spanning a concentration range of
at least seven orders of magnitude (Beck
et al., 2011). Pathogens exploit the host,
its metabolism and proteome for their own
replication. The resulting expenses for the
host provoke the evolution of immune
mechanisms. Immune reactions are ini-
tiated by receptors which recognize con-
served pathogen-associated patterns and
signal via highly interconnected networks
of co-receptors, adapter proteins, and
transcription factors to induce the expres-
sion of anti-pathogenic host proteins.
Pathogens in turn develop corresponding
countermeasures like pathogen-encoded
immune antagonists and bacterial effec-
tor proteins. These facts exemplify the
complexity and richness of the interac-
tions between host- and pathogen-derived
proteomes.
A considerable fraction of host pro-
teins directly or indirectly influences the
replication of pathogens. Irrespective of
whether a protein supports or restricts
replication, the functional understanding
of this interaction can in principle be uti-
lized for therapeutic interventions: Anti-
pathogenic proteins and compounds can
be exogenously administered (like e.g.,
recombinant interferons) whereas pro-
teins which support the replication of a
pathogen (e.g., entry receptors) constitute
potential drug targets. Therefore, an in-
depth knowledge of protein-protein inter-
actions (PPIs) between host and pathogens
is highly desirable. In the past, most PPIs
have been identified in small scale exper-
iments. Recently, large-scale screens (e.g.,
yeast-2-hybrid screens) have been used to
unravel a broader picture of the global PPI
networks.
Durmus¸ Tekir et al. (2012) developed
a novel pathogen-host interaction (PHI)
search tool called PHISTO (www.phisto.
org) and compared the retrieved PHIs
with the network of naive human PPIs
which had been interrogated from the
databases BioGRID, DIP, IntAct, Mint,
and Reactome. The resulting interac-
tion data comprise over 23,000 PPIs
derived from 72 different pathogens.
The authors assessed the tendency of
pathogen-derived proteins to interact with
host hub and/or bottleneck proteins. Hub
proteins are defined by their above-
average number of direct interactions,
whereas bottleneck proteins exhibit a high
betweenness centrality - meaning that an
over-proportional number of connections
between two other proteins in the net-
work go through the respective pro-
tein. Consistent with previous reports
(Calderwood et al., 2007; de Chassey et al.,
2008; Dyer et al., 2008, 2010; Wuchty
et al., 2010; Zhao et al., 2011), Durmus¸
Tekir et al. (2012) find that pathogen
proteins have the significant tendency to
interact with hub and bottleneck pro-
teins of the host. Proteins which are
targeted by 2 (or 3) different viral or
bacterial pathogens show an increasing
centrality within the PPI network of the
host. This finding certainly makes sense.
During infection, relatively few pathogen-
derived proteins face a huge number of
host proteins. In many cases, pathogens
have significantly smaller coding capaci-
ties than their respective host species, for
instance, numerous viruses express less
than 15 different proteins and several bac-
teria translocate a limited number of effec-
tor proteins into the host cell. Pathogens
seemingly solved the discrepancy between
the restricted number of own proteins and
the huge host proteome by targeting cen-
tral elements of the human PPI network.
A comparison of bacteria and viruses
revealed that this trend is even more pro-
nounced in the case of viruses. Potential
explanations might reside in the obliga-
tory intracellular replication or the smaller
genome size of viruses. Thus, it might be
worthwhile to differentiate bacteria into
intracellular and extracellular pathogens
and to order the pathogens according to
their respective coding capacity and/or the
number of pathogen effector proteins.
For the majority of organisms the elu-
cidation of interactomes is still in its
infancy and countless PPIs remain to be
discovered and characterized. Research in
this field has to address some important
questions. For instance, by far none of
the currently available databases is com-
plete. Most databases lack PPIs which have
been individually identified and published
but not listed in databases. For exam-
ple, at the time of the analysis, PHISTO
contained only five Salmonella-human
PPIs - the ones automatically retrievable
from databases like DIP and IntAct - but
misses 38 other known Salmonella-human
PPIs (Schleker et al., 2012). These num-
bers highlight the potential of “hidden”
information that are not easily accessible
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in an automated fashion. Gathering all
the existing information in one single
database is obviously a huge challenge,
but would significantly stimulate the field.
Furthermore, PPI networks are highly
dynamic and critically depend on factors
like cell type, pathogen strain, duration of
infection, pathogen inoculum, and several
other experimental conditions. Therefore,
a fair assessment of the reproducibility and
quality of results are urgently needed and
secondly, the integration of experimental
results and PPI data is essential to retrieve
meaningful interactomes.
In conclusion, large-scale multi-species
comparisons like done by Durmus¸ Tekir
et al. (2012) provide valuable insights into
general mechanisms of PPIs between host
and pathogen. A lot of effort went into
identifying PPIs and comparing interac-
tomes but still numerous questions remain
to be answered. For instance, how strong
is the preference of pathogen proteins
for hub and bottleneck proteins? Is it
possible to turn the table and argue
that if a given human protein is tar-
geted by several pathogens, but neither
has many intraspecies PPIs nor consti-
tute a bottleneck for certain pathways,
that we might have missed some of its
natural interactions? Maybe it might be
a good idea to reassess its interactive
behavior to unravel currently unknown
interactions? Thereby, knowledge about
host-pathogen PPIs would not only allow
to uncover the pathogens’ virulence strate-
gies but might also aid in identifying
host proteins and pathways which are of
central importance in other human dis-
eases (Schleker et al., 2013). Continued
studies and increasing amounts of pre-
cise information will further deepen our
understanding of the interplay between
pathogens and their respective hosts and
hopefully identify some common Achilles’
heels.
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